GlassScriptPhysician profile
Jenny Smith
NPI 1578794947
$1,322.52
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,203 · 2023: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $156.22 | 2021-2023 | |
| Kowa Pharmaceuticals America, INC. | $142.53 | 2021 | |
| Novo Nordisk INC | $141.97 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.91 | 2021-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $109.93 | 2021 | |
| Amgen INC. | $90.19 | 2021 | |
| Amarin Pharma, INC. | $87.76 | 2021 | |
| Abbvie INC. | $73.33 | 2021-2023 | |
| Lilly USA, LLC | $62.36 | 2021-2023 | Jardiance, Emgality, Mounjaro |
| Biohaven Pharmaceuticals, INC. | $43.50 | 2021 | |
| Glaxosmithkline, LLC. | $39.38 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $36.98 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.08 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.09 | 2021 | |
| Janssen Pharmaceuticals, INC | $32.84 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $25.66 | 2021 | |
| Exact Sciences Corporation | $24.32 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $16.68 | 2021 | |
| Esperion Therapeutics, INC. | $16.04 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.02 | 2021 | |
| Eisai INC. | $14.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.